https://latampharmara.com/2014/03/25/cofeprismercadolibre-agreement-to-regulate-advertisement/https://latampharmara.com/wp-content/uploads/2014/03/mercado-libre.jpgMercado Libre logoMercadoLibre logo2014-03-28T22:01:36+00:00monthlyhttps://latampharmara.com/2014/03/18/mexico-and-s-korea-pharma-cooperation-agreement/https://latampharmara.com/wp-content/uploads/2014/03/south-korea1.jpgCOFEPRIS and South Korea MoUHeads of the Mexican and South Korean Health Authorities signing the Memorandum of Understanding. Photo credit: COFEPRIS website.https://latampharmara.com/wp-content/uploads/2014/03/south-korea.jpgsouth korea2015-02-12T20:31:33+00:00monthlyhttps://latampharmara.com/2014/03/10/clinical-trial-applications-in-mexico-decentralization-and-acceleration-of-protocol-approval/https://latampharmara.com/wp-content/uploads/2014/03/clinical.pngclinical trial phases2014-03-11T09:30:16+00:00monthlyhttps://latampharmara.com/2014/03/05/generic-market-in-mexico-up-to-84/2014-03-06T01:09:58+00:00monthlyhttps://latampharmara.com/2014/03/04/movies-for-regulatory-professionals-dallas-buyers-club-2013/https://latampharmara.com/wp-content/uploads/2014/03/dallas-buyers.jpgdallas buyers club2014-03-04T16:21:38+00:00monthlyhttps://latampharmara.com/2014/02/28/gates-foundation-says-new-efforts-needed-to-bolster-pharmacovigilance-systems-in-developing-world/2014-02-28T18:00:08+00:00monthlyhttps://latampharmara.com/2014/02/28/invimaanmat-inter-agency-collaboration-activities/2014-02-28T16:50:21+00:00monthlyhttps://latampharmara.com/central-america/panama/2014-11-25T04:58:00+00:00weekly0.6https://latampharmara.com/central-america/nicaragua/2014-11-24T09:44:58+00:00weekly0.6https://latampharmara.com/central-america/honduras/2014-02-27T22:05:40+00:00weekly0.6https://latampharmara.com/central-america/guatemala/2014-09-24T10:08:19+00:00weekly0.6https://latampharmara.com/central-america/el-salvador/2014-09-24T10:07:44+00:00weekly0.6https://latampharmara.com/central-america/2014-12-04T07:13:32+00:00weekly0.6https://latampharmara.com/2014/02/24/americas-health-authorities-meeting/https://latampharmara.com/wp-content/uploads/2014/02/acapulco.jpgHealth Authority SummitRepresentatives of the American Health Authorities. Photo: COFEPRIS website. 2014-02-25T01:17:18+00:00monthlyhttps://latampharmara.com/2014/02/17/recommended-movie-fight-to-live-2012/2014-02-17T02:27:22+00:00monthlyhttps://latampharmara.com/2014/02/01/market-access-interview/2014-01-31T23:06:18+00:00monthlyhttps://latampharmara.com/2013/12/15/top-10-pharma-products-on-the-pipeline/2013-12-16T01:00:41+00:00monthlyhttps://latampharmara.com/2013/12/11/anvisa-approves-track-and-trace-system/2013-12-11T19:26:53+00:00monthlyhttps://latampharmara.com/2013/12/11/list-of-fda-advisory-committees/2013-12-11T16:12:04+00:00monthlyhttps://latampharmara.com/2013/12/09/brazil-makes-proposed-outsourcing-regulations-available-for-comment/2013-12-10T00:54:52+00:00monthlyhttps://latampharmara.com/2013/12/06/puerto-rico-to-opportunistically-pursue-biologics-to-regenerate-industry/2013-12-06T01:13:23+00:00monthlyhttps://latampharmara.com/2013/11/29/mexico-at-the-vanguard-with-new-combination-drug/2013-11-29T01:02:47+00:00monthlyhttps://latampharmara.com/2013/11/27/argentina-site-master-file-now-required-by-anmat-for-national-sites/2014-08-21T07:00:47+00:00monthlyhttps://latampharmara.com/2013/11/06/brazil-anvisa-bans-lorcaserin-belviq/2015-03-11T15:01:30+00:00monthlyhttps://latampharmara.com/2013/11/04/mou-between-mexican-and-chinese-health-authorities/2013-11-04T02:08:59+00:00monthlyhttps://latampharmara.com/2013/10/28/brazil-overview-of-api-registration/2015-01-20T10:15:02+00:00monthlyhttps://latampharmara.com/2013/10/22/mexico-and-costa-rica-sign-cooperation-agreement-on-drugs-and-vaccines/2013-10-22T16:14:57+00:00monthlyhttps://latampharmara.com/2013/10/22/argentina-checklist-for-gmp-inspections-of-api-facilities/2013-10-22T11:28:04+00:00monthlyhttps://latampharmara.com/mexico/cofepris-the-mexican-health-authority/2016-05-23T09:53:52+00:00weekly0.6https://latampharmara.com/2013/10/18/mexico-new-guidelines-for-the-acceptance-of-gmp-certificates/2015-04-11T06:15:56+00:00monthlyhttps://latampharmara.com/fundamentals-of-regulatory-affairs/health-authorities-of-international-reference/ema/https://latampharmara.com/wp-content/uploads/2013/05/screen-shot-2013-05-31-at-2-55-58-am.pngScreen shot 2013-05-31 at 2.55.58 AM2013-10-18T10:25:48+00:00weekly0.6https://latampharmara.com/2013/10/17/new-domain/2013-10-16T23:01:27+00:00monthlyhttps://latampharmara.com/get-in-touch/2013-10-16T17:39:54+00:00weekly0.6https://latampharmara.com/mexico/pharmacovigilance/2013-11-20T21:54:29+00:00weekly0.6https://latampharmara.com/mexico/new-biotech-regulations-april-2012/https://latampharmara.com/wp-content/uploads/2013/05/screen-shot-2013-05-23-at-11-53-07-pm.pngBiotech regulations mexico global2013-10-16T17:35:29+00:00weekly0.6https://latampharmara.com/mexico/gmp-inspection-by-cofepris/2015-03-17T18:35:07+00:00weekly0.6https://latampharmara.com/mexico/authorized-third-parties/2014-08-28T07:39:28+00:00weekly0.6https://latampharmara.com/mexico/local-clinical-trials-requirement/2014-06-24T18:49:50+00:00weekly0.6https://latampharmara.com/mexico/new-molecule-commitee/https://latampharmara.com/wp-content/uploads/2013/05/nmc.pngnmcNew Molecule Committee procedure (in Spanish - from COFEPRIS webpage)2013-10-16T17:14:12+00:00weekly0.6https://latampharmara.com/mexico/drug-registration-in-mexico/2015-04-16T12:31:46+00:00weekly0.6https://latampharmara.com/mexico/https://latampharmara.com/wp-content/uploads/2012/09/screen-shot-2013-10-16-at-6-33-03-pm.pngMexico economy 2013https://latampharmara.com/wp-content/uploads/2012/09/screen-shot-2012-09-21-at-1-33-52-pm.pngMexico economy2013-12-25T11:15:35+00:00weekly0.6https://latampharmara.com/colombia/registration-of-drug-products-in-colombia/new-drug-products-included-in-colombian-pharmacological-norms-national-manufacturing/2014-11-16T04:41:42+00:00weekly0.6https://latampharmara.com/colombia/registration-of-drug-products-in-colombia/new-drug-products-included-in-colombian-pharmacological-norms-foreign-manufacturing/2015-04-09T08:50:12+00:00weekly0.6https://latampharmara.com/argentina/labeling/2013-10-16T16:02:17+00:00weekly0.6https://latampharmara.com/argentina/labeling/new-regulations-and-others/https://latampharmara.com/wp-content/uploads/2012/09/screen-shot-2013-10-16-at-5-51-21-pm.pnglabeling otchttps://latampharmara.com/wp-content/uploads/2012/09/screen-shot-2013-06-09-at-11-53-01-pm.pngOTC labeling regulation ANMAT2013-10-16T16:00:12+00:00weekly0.6https://latampharmara.com/argentina/labeling/new-gluten-content-claim-requirement/https://latampharmara.com/wp-content/uploads/2013/10/screen-shot-2013-10-16-at-5-51-38-pm.pnggluten content claim2013-10-16T15:59:19+00:00weekly0.6https://latampharmara.com/argentina/august-2012-orphan-drugs-new-regulation/https://latampharmara.com/wp-content/uploads/2012/09/screen-shot-2013-10-16-at-5-47-40-pm.pngorphan drug regulations anmathttps://latampharmara.com/wp-content/uploads/2012/09/screen-shot-2013-06-09-at-11-54-59-pm.pngOrphan drugs Argentina ANMAT2013-10-16T15:50:08+00:00weekly0.6https://latampharmara.com/argentina/gmp-inspections-regulatory-aspects/2013-10-16T15:46:46+00:00weekly0.6https://latampharmara.com/argentina/pharmacovigilance/2013-10-16T15:43:09+00:00weekly0.6https://latampharmara.com/argentina/variations/2013-10-16T15:37:44+00:00weekly0.6https://latampharmara.com/argentina/drug-product-certificate-renewal-in-argentina/https://latampharmara.com/wp-content/uploads/2012/09/screen-shot-2013-06-09-at-11-47-52-pm.pngScreen shot 2013-06-09 at 11.47.52 PMhttps://latampharmara.com/wp-content/uploads/2012/09/screen-shot-2013-06-09-at-11-46-23-pm.pngScreen shot 2013-06-09 at 11.46.23 PM2013-10-16T15:21:02+00:00weekly0.6https://latampharmara.com/argentina/first-batch-verification/https://latampharmara.com/wp-content/uploads/2012/09/screen-shot-2013-10-16-at-5-14-34-pm.pngfirst batch verificationhttps://latampharmara.com/wp-content/uploads/2012/09/screen-shot-2013-06-09-at-11-49-53-pm.pngFirst batch verification2013-10-16T15:19:51+00:00weekly0.6https://latampharmara.com/argentina/registration-of-biological-drug-products-in-argentina/2013-10-16T15:13:37+00:00weekly0.6https://latampharmara.com/argentina/drug-registration-in-argentina/2015-04-10T09:54:14+00:00weekly0.6https://latampharmara.com/argentina/https://latampharmara.com/wp-content/uploads/2012/09/screen-shot-2012-09-20-at-11-49-02-pm.pngHealthcare coverage breakdown argentina infograph48% Argentinians are covered under the social security (obras sociales) scheme, 9% are subscribed to private insurance services, 4% are beneficiaries both of private health insurance and social security, and 38% don't count on any formal health insurance system, using the public free healthcare services.https://latampharmara.com/wp-content/uploads/2012/09/screen-shot-2012-09-20-at-8-04-22-pm.pngScreen shot 2012-09-20 at 8.04.22 PM2013-10-16T14:58:12+00:00weekly0.6https://latampharmara.com/argentina/anmat-the-argentinean-health-authority/https://latampharmara.com/wp-content/uploads/2012/09/screen-shot-2013-05-24-at-12-25-33-am.pngANMAT organigramhttps://latampharmara.com/wp-content/uploads/2012/09/screen-shot-2013-05-24-at-12-24-04-am.pngANMAThttps://latampharmara.com/wp-content/uploads/2012/09/screen-shot-2012-10-03-at-2-33-07-pm.pngScreen shot 2012-10-03 at 2.33.07 PM2015-01-20T18:17:19+00:00weekly0.6https://latampharmara.com/blog/2013-07-31T09:08:10+00:00weekly0.6https://latampharmara.com/fundamentals-of-regulatory-affairs/2013-07-31T09:06:52+00:00weekly0.6https://latampharmara.com/health-research/https://latampharmara.com/wp-content/uploads/2012/09/screen-shot-2012-09-11-at-1-50-49-pm.pngScreen shot 2012-09-11 at 1.50.49 PM2013-07-31T09:06:39+00:00weekly0.6https://latampharmara.com/colombia/2013-07-31T09:06:25+00:00weekly0.6https://latampharmara.com/colombia/registration-of-drug-products-in-colombia/2014-05-20T19:57:49+00:00weekly0.6https://latampharmara.com/2013/07/13/anmat-launches-online-platform-to-report-drug-adverse-reactions/2013-07-13T16:33:10+00:00monthlyhttps://latampharmara.com/2013/07/05/labeling-update-argentina-gluten-freegluten-containing-compulsory-claim/https://latampharmara.com/wp-content/uploads/2013/07/sin-tacc.jpgsin tacc2013-07-05T12:05:56+00:00monthlyhttps://latampharmara.com/health-research/the-undp-millenium-development-goals-and-the-pharma-industry/2013-07-05T11:01:31+00:00weekly0.6https://latampharmara.com/health-research/mercosur/https://latampharmara.com/wp-content/uploads/2013/05/screen-shot-2013-06-01-at-12-42-03-am.pngMERCOSUR2013-07-05T11:01:30+00:00weekly0.6https://latampharmara.com/health-research/85-2/2013-07-05T11:01:29+00:00weekly0.6https://latampharmara.com/health-research/economy-101-measuring-a-countrys-economy/2013-07-05T11:01:27+00:00weekly0.6https://latampharmara.com/fundamentals-of-regulatory-affairs/health-authorities-of-international-reference/fda/https://latampharmara.com/wp-content/uploads/2013/05/screen-shot-2013-05-31-at-2-34-17-am.pngScreen shot 2013-05-31 at 2.34.17 AM2013-07-05T11:00:04+00:00weekly0.6https://latampharmara.com/fundamentals-of-regulatory-affairs/health-authorities-of-international-reference/2013-07-05T11:00:01+00:00weekly0.6https://latampharmara.com/fundamentals-of-regulatory-affairs/the-submission-dossier/stability-studies/https://latampharmara.com/wp-content/uploads/2013/07/climate-zones-table.pngclimate zones table2013-07-05T11:00:00+00:00weekly0.6https://latampharmara.com/fundamentals-of-regulatory-affairs/the-submission-dossier/https://latampharmara.com/wp-content/uploads/2013/05/screen-shot-2013-05-31-at-1-36-01-pm.pngCTD triangle structurefrom www.ich.org2015-02-23T07:15:28+00:00weekly0.6https://latampharmara.comdaily1.02016-05-23T09:53:52+00:00